Project Grant R01HL173037
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Children's Hospital of Philadelphia a $180,174 Project Grant effective August 1, 2025, through July 31, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). This award supports the development of an improved framework for designing next-generation pediatric acute respiratory distress syndrome (ARDS) clinical trials. The research addresses limitations in current trial methodologies...
- Federal Grant Award Summary Boston Children's Hospital received a $279,644 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) for the period September 1, 2025, through August 31, 2027. The project, titled "Time to ROSC as a Novel Outcome for Pediatric Cardiac Arrest Trials," focuses on developing improved trial design methodologies to advance randomized controlled trials (RCTs) for pediatric...
- Federal Project Grant Award Summary Baylor College of Medicine received a $613,399 Project Grant award dated September 16, 2025, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports research extending through June 30, 2029, to develop machine learning (ML)-enabled clinical decision support (CDS) tools for early detection and mitigation of acute kidney injury (AKI) following cardiac surgery. The project...
- The National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865), awarded a $286,820 Project Grant to Children's Hospital Los Angeles (CHLA) on April 1, 2025. The grant funding will support the "DEATH ONE HOUR AFTER TERMINAL EXTUBATION (DONATE) 2.0 STUDY", which aims to validate the performance of the DONATE machine learning model in predicting whether a patient will die within one...
- The National Institute of Child Health and Human Development (NICHD) awarded Boston Children's Hospital a $1,991,224 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) effective September 1, 2025 through August 31, 2027. This award supports the development and implementation of TETRIS (Trends and Epidemiology Through Real-Time Injury Surveillance), a novel pediatric injury surveillance system utilizing physician-informed natural language...
- This federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $117,750 to the Ann & Robert H Lurie Children's Hospital of Chicago to develop and implement a remote patient monitoring dashboard that links parents' real-time vital sign data and symptom reports to pediatric patients' electronic health records. The goal is to facilitate more informed, remote adjustments to ventilator settings for children dependent...
- Federal Project Grant Award Summary Connecticut Children's Medical Center received a $156,340 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 15, 2025, with completion targeted by May 31, 2030. This Mentored Patient-Oriented Research Career Development (K23) award supports Dr. Siddika Mulchan's five-year research program investigating provider-focused interventions to improve health outcomes...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Children's Hospital of Philadelphia Research Institute a Project Grant totaling $135,000 under the Cardiovascular Diseases Research program (CFDA 93.837) on July 16, 2025, with a completion date of June 30, 2030. This grant funds research led by Dr. Jelte Kelchtermans to develop predictive models and risk assessment tools for pediatric asthma exacerbations triggered by ambient air pollution (AAP)...
- This Project Grant from the National Science Foundation Division of Information and Intelligent Systems provides $625,000 to Duke University to develop an interpretable artificial intelligence framework for improving care of critically ill patients. The framework incorporates novel matching techniques known as Almost-Matching-Exactly to analyze observational data from patient treatment and emulate a randomized controlled trial. By matching each treated patient to similar untreated patients,...
- This Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program provides $612,137 to the University of Maryland, College Park to develop a new machine learning framework for anesthesia risk stratification and decision support. The primary objectives are to: 1) automate the processing of electronic anesthesia data, 2) create a semi-supervised generative adversarial network for risk stratification, 3) build an interpretable deep...
CLINICAL DECISION SUPPORT FOR EARLY DETECTION OF DETERIORATION IN HOSPITALIZED CHILDREN - PROJECT SUMMARY HOSPITALIZED CHILDREN WHO EXPERIENCE CARDIOPULMONARY DETERIORATION ARE AT INCREASED RISK FOR MORTALITY AND LONG- TERM MORBIDITY. BECAUSE TIMELY INTERVENTION INCREASES SURVIVAL IN CHILDREN, IT IS CRITICALLY IMPORTANT TO IDENTIFY CARDIOPULMONARY DETERIORATION EVENTS AS EARLY AS POSSIBLE. HOWEVER, THE CURRENT PARADIGM FOR DETECTING THESE EVENTS IN ADVANCE HAS SEVERAL GAPS. FIRST, EXISTING RISK PREDICTION METHODS CAN LEAD TO FRAGMENTED CARE, AS EACH UNIT EMPLOYS DIFFERENT TOOLS FOR PREDICTING SPECIFIC OUTCOMES. FOR EXAMPLE, RISK PREDICTION WITHIN THE EMERGENCY DEPARTMENT (ED) IS TARGETED TOWARD TRIAGE; WARD-BASED TOOLS PREDICT THE RISK OF BEING TRANSFERRED TO THE INTENSIVE CARE UNIT (ICU), WHILE THE ICU FOCUSES ON DETERMINING THE LIKELIHOOD OF DEATH OR CARDIAC ARRESTS. TRANSITIONING FROM MULTIPLE, SILOED RISK ASSESSMENT TOOLS TO A SINGLE, HOSPITAL-WIDE CARDIOPULMONARY DETERIORATION PREDICTION MODEL COULD SIGNIFICANTLY IMPROVE OUTCOMES FOR CHILDREN. A SECOND CRITICAL GAP IS THAT CURRENT PREDICTION MODEL OUTPUTS ARE NOT ACCOMPANIED BY HELPFUL EXPLANATIONS, A NEED UNMET BY STANDARD MACHINE LEARNING (ML) EXPLAINERS DUE TO INHERENT LIMITATIONS. DEVELOPING NEW ALGORITHMS THAT PROVIDE REAL-TIME INTERPRETATIONS OF MODEL OUTPUTS MAY INCREASE SITUATIONAL AWARENESS, DECREASE DIAGNOSTIC DELAY, AND ENABLE BETTER TREATMENT SELECTION. THIRD, TO ENSURE HIGH USAGE AND EFFECTIVE DECISION-MAKING, ANY NEW MODEL SHOULD BE ACCOMPANIED BY A USER INTERFACE EXPLICITLY DESIGNED USING HUMAN FACTORS ENGINEERING PRINCIPLES. THE LONG-TERM GOAL IS TO IMPROVE OUTCOMES AMONG CHILDREN EXPERIENCING CARDIOPULMONARY DETERIORATION BY ENABLING BETTER QUALITY OF CARE. THE OVERALL OBJECTIVE OF THIS PROJECT IS TO DEVELOP A NEW CLINICAL DECISION SUPPORT (CDS) TOOL THAT IS ACCURATE, INTERPRETABLE, AND ACTIONABLE FOR EARLY DETECTION OF CARDIOPULMONARY DETERIORATION EVENTS IN CHILDREN. IN AIM 1, WE WILL USE ELECTRONIC HEALTH RECORD (EHR) DATA FROM PEDIATRIC ADMISSIONS TO FOUR ACADEMIC HOSPITALS AND ML TO DERIVE AND EXTERNALLY VALIDATE A NEW HOSPITAL-WIDE CARDIOPULMONARY DETERIORATION PREDICTION MODEL AND COMPARE PERFORMANCES TO OUR PRELIMINARY MODEL. IN AIM 2, WE WILL DEVELOP NOVEL ALGORITHMS THAT PROVIDE PHYSIOLOGICAL EXPLANATIONS AND CLINICAL CONTEXT FOR MODEL PREDICTIONS FOR A GIVEN PATIENT. FINALLY, IN AIM 3, WE WILL CREATE A NEW CDS TOOL THAT EMBEDS THE BEST-PERFORMING PREDICTION TOOL AND EXPLAINER ALGORITHM OUTPUTS WITHIN A GRAPHICAL USER INTERFACE PURPOSEFULLY DESIGNED TO FACILITATE INCREASED USER INTERACTION. THE PROPOSED RESEARCH IS INNOVATIVE BECAUSE IT INCORPORATES DEEP LEARNING-BASED PEDIATRIC RISK PREDICTION, REAL-TIME EXPLAINABLE ALGORITHMS WITH HIGHLIGHTED CLINICAL CONTEXT, AND HUMAN FACTORS ENGINEERING FOR DEVELOPING THE CDS TOOL. IN ADDITION, THE PROPOSED WORK IS SIGNIFICANT BECAUSE IT WILL RESULT IN A NEW, ACCURATE, INTERPRETABLE, EFFICIENT, AND USER-FRIENDLY CDS TOOL FOR RISK ASSESSMENT THROUGHOUT A PEDIATRIC HOSPITAL. ULTIMATELY, THIS POWERFUL TOOL WILL ENABLE EARLY RECOGNITION OF PEDIATRIC CARDIOPULMONARY DETERIORATION EVENTS, FACILITATING TIMELY DIAGNOSIS AND INTERVENTION TO IMPROVE OUTCOMES AMONG HOSPITALIZED CHILDREN.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $18.0k | 3/16/26 | ||
| Not listed | $571.0k | 2/26/26 | ||
| Not listed | $53.6k | 7/23/25 | ||
| Not listed | $53.6k | 7/23/25 | ||
| Not listed | $482.5k | 3/14/25 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
0000003708S | ANN & Robert H Lurie Childrens Hospital Of Chicago | Project Grant R01HL173037 | $133.1k | 7/31/25 | |
0000003702S | University Of Chicago | Project Grant R01HL173037 | $125.1k | 7/31/25 |